Jobs
View more job listings or post a job
Gate Bioscience Director of Toxicology
Nura Bio Director of Toxicology
Nura Bio Vice President of CMC
MilliporeSigma Emerging Biotech Market Development Manager - San Fransisco
How Cancer LLC Social Media Digital Marketing Specialist  
How Cancer LLC Syndicated National Writer - Cancer 
University of California, Davis SCREENING SUPERVISOR
InnoAlliance Scientist/Sr Scientist of Bioanalysis & Biomarkers
Post a job

Symposium

[Free Online Webcast] Regenerative Medicine: Latest Advances and Case Studies


Speakers: Peter Santa Maria, MD, PhD, Professor, Stanford University; David Myung, MD, PhD, Professor, Stanford University; John Ramunas, PhD, CEO, Rejuvenation Technologies; Luis Alvarez, PhD, CEO, Theradaptive
Organizers: Peter Staehr and Shichang Miao
Date: 2021-12-06
Time: 8:30-12:40 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2021-12-05  (it will close sooner if the seating cap is reached)

About the Topic

Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering, and the production of artificial organs. Regrowing, repairing, or replacing damaged or diseased cells, organs or tissues has the potential to tremendously benefit patients and our society as a whole. The mini-symposium intends to give the attendees some insight into these various areas of regenerative medicine.

The speakers will present on the translational development of the tympanic membrane to improve or enable hearing as well as the development of biomaterials for the cornea to improve the vision. What development techniques are available and what challenges must be overcome?

Another presentation provides insights on how to possibly treat fatal diseases of aging. When telomeres become too short, cells can't function, which is the major driver of disease and aging. Using mRNA encoding telomerase (TERT mRNA) has the potential to reverse telomere shortening. 

The development of biomaterials for orthopedic applications is another important area in regenerative medicine. One approach is to deliver therapeutic proteins that enhance healing of implants. Coating the surface of implants with these proteins like paint can make them more readily available for cells of the body to interact with.

Tentative Agenda:

8:30 Am – 8:40 AM: Welcome and Introduction

8:40 AM – 9:30 AM: Engineering protein interfaces to create regenerative implants. Luis Alvarez, PhD, CEO, Theradaptive

9:30 AM – 10:20 AM: Regenerative biomaterials for the cornea. David Myung, MD, PhD, Professor, Stanford University

10:20 AM – 10:30 AM: Break

10:30 AM – 11:20 AM: Telomere extension using TERT mRNA. John Ramunas, PhD, CEO, Rejuvenation Technologies

11:20 AM – 12:10 PM: The translational journey of tympanic membrane regeneration. Peter Santa Maria, MD, PhD, Professor, Stanford University

12:10 PM – 12:40 PM: Panel Discussion

 


2025-02-13, [Free Online] The Science and Stories of Promising Biotech Startups
2025-02-26, [In-Person] Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
2025-04-01, [For vendors ONLY] Seattle PBSS Seminar Luncheon Vendor Show
2025-04-09, [In-Person] Cell Therapy Discovery and Development: Fundamentals, Strategies and Best Practices (jointly by PBSS and RAPS-SF)
2025-04-22, [Free Online Workshop] Career Transitions for Research Scientists: BD/Sales in CROs, CDMOs, and Lab Products & Instruments
2025-04-25, [In-Person] Drug Metabolism Fundamentals and Metabolite Identification
2025-05-05, [Free Online] Highlights of 2024 FDA Drug Approvals
2025-05-12, [In-Person] Preclinical Pharmacology Studies and Translational Medicine for Drug Discovery and Development
2025-06-02, [In-Person] Metabolism and Transport-mediated Drug-Drug Interaction: Current Practices, Regulatory Guidances, and Their Impact on Drug Development
©Pharmaceutical & BioScience Society, International; Last Modified: 2/12/2025; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Allucent Experts bringing development innovation w/ClinPharm Modeling & Simulation deliverables to inform dose, study design, modeling+development strategies.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad